These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9123597)

  • 1. The regulation of membrane cofactor protein (CD46) expression in transgenic mice: the importance of the first 125 BP of the 3' untranslated region.
    Miyagawa S; Ikawa M; Kominami K; Tanaka H; Mikata S; Matsuda H; Seya T; Shirakura R; Okabe M
    Transplant Proc; 1997; 29(1-2):941-2. PubMed ID: 9123597
    [No Abstract]   [Full Text] [Related]  

  • 2. Difference of expression levels between gene technological product delta CYT-MCP(CD46) and intact MCP(CD46) in transgenic mice.
    Miyagawa S; Ikawa M; Kominami K; Yoshimura Y; Tanaka H; Mikata S; Shirakura R; Matsuda H; Yanagi Y; Seya T; Okabe M
    Transplant Proc; 1996 Apr; 28(2):585-6. PubMed ID: 8623285
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulation of membrane cofactor protein (CD46) expression by the 3' untranslated region in transgenic mice.
    Miyagawa S; Mikata S; Tanaka H; Ikawa M; Kominami K; Seya T; Nishimune Y; Shirakura R; Okabe M
    Biochem Biophys Res Commun; 1997 Apr; 233(3):829-33. PubMed ID: 9168942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells.
    Kooyman D; Byrne G; McClellan S; Nielsen D; Kagan D; Coffman T; Masahide T; Waldmann H; Platt J; Logan J
    Transplant Proc; 1994 Jun; 26(3):1241. PubMed ID: 7518117
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of pigs transgenic for human regulators of complement activation.
    Yannoutsos N; Langford GA; Cozzi E; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1995 Feb; 27(1):324-5. PubMed ID: 7533399
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of pigs transgenic for human regulators of complement activation using YAC technology.
    Langford GA; Cozzi E; Yannoutsos N; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1996 Apr; 28(2):862-3. PubMed ID: 8623438
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice.
    Diamond LE; Oldham ER; Platt JL; Waldmann H; Tone M; Walsh LA; Logan JS
    Transplant Proc; 1994 Jun; 26(3):1239. PubMed ID: 7518115
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo evaluation of human membrane cofactor protein in transgenic mice.
    IJzermans JN; Schraa EO; Bonthuis F; Yannnoutsos N; Marquet RL
    Transplant Proc; 1996 Apr; 28(2):671-2. PubMed ID: 8623336
    [No Abstract]   [Full Text] [Related]  

  • 11. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.
    Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD46 aberrant splicing in transgenic mice.
    Mulder LC; Rossini M; Mora M
    Gene; 1997 Feb; 186(1):83-6. PubMed ID: 9047349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction and expression of human CD59 gene in the canine kidney.
    Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Tomita N; Kaneda Y; Tanaka K
    Transplant Proc; 1994 Jun; 26(3):1315-7. PubMed ID: 7518127
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region.
    Nomura M; Kurita-Taniguchi M; Kondo K; Inoue N; Matsumoto M; Yamanishi K; Okabe M; Seya T
    Eur J Immunol; 2002 Oct; 32(10):2954-64. PubMed ID: 12355449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
    Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of human DAF and MCP on pig endothelial cells protects from human complement.
    Carrington CA; Richards AC; Cozzi E; Langford G; Yannoutsos N; White DJ
    Transplant Proc; 1995 Feb; 27(1):321-3. PubMed ID: 7533398
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
    Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo.
    Christiansen D; Devaux P; Réveil B; Evlashev A; Horvat B; Lamy J; Rabourdin-Combe C; Cohen JH; Gerlier D
    J Virol; 2000 May; 74(10):4672-8. PubMed ID: 10775604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human decay accelerating factor in transgenic pigs.
    Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
    Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.